Evofem Biosciences
EVFM0.00760.00% ( 0.0000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Evofem Biosciences(EVFM) the Revenue is 899 K (+6.39%);the EBIT is -4.569 M (-1497%);the EPS is -0.0412 (-268 times%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B6.39%
----
----
EBIT
-0.00B1497.25%
----
----
EPS
-0.041226829.87%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf